Sree B. Chalasani

987 total citations
15 papers, 84 citations indexed

About

Sree B. Chalasani is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Surgery. According to data from OpenAlex, Sree B. Chalasani has authored 15 papers receiving a total of 84 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Sree B. Chalasani's work include Cancer Genomics and Diagnostics (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Gastric Cancer Management and Outcomes (3 papers). Sree B. Chalasani is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Gastric Cancer Management and Outcomes (3 papers). Sree B. Chalasani collaborates with scholars based in United States and Ireland. Sree B. Chalasani's co-authors include William G. Hocking, Roxann Rokey, Yelena Y. Janjigian, David P. Kelsen, David H. Ilson, Hemender S. Vats, Geoffrey Y. Ku, Yaelle Tuvy, Abraham J. Wu and Joanne F. Chou and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Sree B. Chalasani

15 papers receiving 83 citations

Peers

Sree B. Chalasani

ONCOL

PRM

SURGE

PHYSI

Kate Wilkinson Australia

Henk van Halteren Netherlands

Lynn Chong Australia

Bibek Das United Kingdom

Yasushi Rino Japan

M. Bailón-Cuadrado Spain

A. Poveda Spain

Xuming Hu China

Cunchuan Wang China

Ahmed Abdelhakeem United States

Kate Wilkinson Australia

Sree B. Chalasani

62 ×1.6

ONCOL

26 ×1.0

PRM

15 ×0.6

SURGE

23 ×1.1

10 ×0.6

PHYSI

Citations per year, relative to Sree B. Chalasani Sree B. Chalasani (= 1×) peers Kate Wilkinson

Countries citing papers authored by Sree B. Chalasani

Since Specialization

Citations

This map shows the geographic impact of Sree B. Chalasani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sree B. Chalasani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sree B. Chalasani more than expected).

Fields of papers citing papers by Sree B. Chalasani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sree B. Chalasani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sree B. Chalasani. The network helps show where Sree B. Chalasani may publish in the future.

Co-authorship network of co-authors of Sree B. Chalasani

This figure shows the co-authorship network connecting the top 25 collaborators of Sree B. Chalasani. A scholar is included among the top collaborators of Sree B. Chalasani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sree B. Chalasani. Sree B. Chalasani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Artz, Oliver, Peter Ntiamoah, Caroline Weipert, et al.. (2025). Acquired High Tumor Mutational Burden and Activity of Immunotherapy after Targeted Therapy in Microsatellite Stable Colorectal Cancer. Clinical Cancer Research. 32(6). 1100–1109. 1 indexed citations

Keane, Fergus, Henry Walch, Joanne F. Chou, et al.. (2024). Molecular and Clinical Determinants of Acquired Resistance and Treatment Duration for Targeted Therapies in Colorectal Cancer. Clinical Cancer Research. 30(12). 2672–2683. 5 indexed citations

Moy, Ryan H., Megan Greally, Joanne F. Chou, et al.. (2022). Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma. Cancer Chemotherapy and Pharmacology. 89(2). 255–265. 1 indexed citations

Wu, Abraham J., Smita Sihag, Henry Walch, et al.. (2022). Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma: Final results.. Journal of Clinical Oncology. 40(16_suppl). 4029–4029. 5 indexed citations

Ku, Geoffrey Y., Abraham J. Wu, Smita Sihag, et al.. (2021). Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma.. Journal of Clinical Oncology. 39(3_suppl). 226–226. 5 indexed citations

Diplas, Bill H., Ryan Ptashkin, Andrea Cercek, et al.. (2021). Clinical relevance of clonal hematopoiesis in metastatic gastrointestinal malignancies.. Journal of Clinical Oncology. 39(15_suppl). e16082–e16082. 1 indexed citations

Won, Elizabeth, Walid K. Chatila, Jaclyn F. Hechtman, et al.. (2019). Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric Cancer. Clinical Cancer Research. 25(13). 3811–3817. 14 indexed citations

Park, Wungki, Winston Wong, Kenneth H. Yu, et al.. (2019). Homologous recombination deficiency (HRD): A biomarker for first-line (1L) platinum in advanced pancreatic ductal adenocarcinoma (PDAC).. Journal of Clinical Oncology. 37(15_suppl). 4132–4132. 7 indexed citations

Varghese, Anna M., Jinru Shia, Alice Zervoudakis, et al.. (2017). Clinical characterization of pancreatic ductal adenocarcinomas (PDAC) with mismatch repair (MMR) gene mutations.. Journal of Clinical Oncology. 35(15_suppl). e15791–e15791. 3 indexed citations

10.

Janjigian, Yelena Y., Geoffrey Y. Ku, Joanne F. Chou, et al.. (2015). Phase II study of FOLFOX plus regorafenib (REGO) in patients with unresectable or metastatic esophagogastric (EG) cancer.. Journal of Clinical Oncology. 33(15_suppl). 4053–4053. 5 indexed citations

11.

Chalasani, Sree B., et al.. (2013). A Novel Case of Diabetic Muscle Necrosis in a Patient with Cystic Fibrosis-Related Diabetes. Clinical Medicine & Research. 11(3). 113–116. 3 indexed citations

12.

Chalasani, Sree B., et al.. (2012). Unusual Presentation of a Rare Cancer: Histiocytic Sarcoma in the Brain 16 Years After Treatment for Acute Lymphoblastic Leukemia. Clinical Medicine & Research. 11(1). 31–35. 15 indexed citations

13.

Olszewski, Adam J., Michael L. Grossbard, Michael Chung, et al.. (2012). Phase I Study of Oxaliplatin in Combination with Gemcitabine, Irinotecan, and 5-Fluorouracil/Leucovorin (G-FLIE) in Patients with Metastatic Solid Tumors Including Adenocarcinoma of the Pancreas. Journal of Gastrointestinal Cancer. 44(2). 182–189. 2 indexed citations

14.

Chalasani, Sree B., et al.. (2010). Stiff Heart Syndrome. Clinical Medicine & Research. 9(2). 92–99. 9 indexed citations

15.

Chalasani, Sree B., et al.. (2009). Metastatic Virilizing Adrenocortical Carcinoma: A Rare Case of Cure with Surgery and Mitotane Therapy. Clinical Medicine & Research. 7(1-2). 48–51. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact